Bloomage Biotechnology Corp Ltd Market Cap ($2.45 Billion)
Market Cap & Net Worth: Bloomage Biotechnology Corp Ltd (688363)
Bloomage Biotechnology Corp Ltd market cap. Bloomage Biotechnology Corp Ltd (SHG:688363) has a market capitalization of $2.45 Billion (CN¥16.74 Billion) as of November 10, 2026. Listed on the SHG stock exchange, this China-based company holds position #5325 globally and #908 in its home market, demonstrating a 6.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bloomage Biotechnology Corp Ltd's stock price CN¥34.76 by its total outstanding shares 481678242 (481.68 Million). Also see cash efficiency ratio of Bloomage Biotechnology Corp Ltd for how efficiently the company converts equity into cash flow.
Bloomage Biotechnology Corp Ltd Market Cap History (2019–2026)
Bloomage Biotechnology Corp Ltd market cap history from 2019 to 2026. Data shows change from $5.79 Billion to $2.45 Billion (-11.82% CAGR). Check 688363 stock price for real-time trading data and today's change.
Bloomage Biotechnology Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bloomage Biotechnology Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 688363 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.73x
Bloomage Biotechnology Corp Ltd's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.54x
Bloomage Biotechnology Corp Ltd's market cap is 10.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $5.79 Billion | $1.89 Billion | $585.61 Million | 3.07x | 9.89x |
| 2020 | $10.20 Billion | $2.63 Billion | $645.84 Million | 3.87x | 15.79x |
| 2021 | $10.83 Billion | $4.95 Billion | $782.33 Million | 2.19x | 13.84x |
| 2022 | $9.47 Billion | $6.36 Billion | $970.92 Million | 1.49x | 9.76x |
| 2023 | $4.72 Billion | $6.08 Billion | $592.56 Million | 0.78x | 7.96x |
| 2024 | $3.60 Billion | $5.37 Billion | $174.27 Million | 0.67x | 20.64x |
| 2025 | $3.08 Billion | $4.20 Billion | $292.06 Million | 0.73x | 10.54x |
Competitor Companies of 688363 by Market Capitalization
Companies near Bloomage Biotechnology Corp Ltd in the global market cap rankings as of November 10, 2026. Also see balance sheet size of Bloomage Biotechnology Corp Ltd for a full breakdown of the balance sheet.
Key companies related to Bloomage Biotechnology Corp Ltd by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #93 globally with a market cap of $215.12 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #237 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #247 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #311 globally with a market cap of $85.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Linde plc Ordinary Shares | NASDAQ:LIN | $215.12 Billion | $515.25 |
| #237 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #247 | Air Liquide SA | PA:AI | $101.06 Billion | €187.78 |
| #311 | Sherwin-Williams Co | NYSE:SHW | $85.30 Billion | $344.10 |
Market Capitalization of Bloomage Biotechnology Corp Ltd (2019–2026)
Market capitalization of Bloomage Biotechnology Corp Ltd from 2019 to today. Between 2019 and today, Bloomage Biotechnology Corp Ltd's market cap moved from $5.79 Billion to $ 2.45 Billion, with a yearly change of -11.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.45 Billion | -20.42% |
| 2025 | CN¥3.08 Billion | -14.42% |
| 2024 | CN¥3.60 Billion | -23.74% |
| 2023 | CN¥4.72 Billion | -50.19% |
| 2022 | CN¥9.47 Billion | -12.55% |
| 2021 | CN¥10.83 Billion | +6.20% |
| 2020 | CN¥10.20 Billion | +76.03% |
| 2019 | CN¥5.79 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Bloomage Biotechnology Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.45 Billion USD |
| MoneyControl | $2.45 Billion USD |
| MarketWatch | $2.45 Billion USD |
| marketcap.company | $2.45 Billion USD |
| Reuters | $2.45 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by… Read more